Idio.Ns
IDIO.NS maintains a relatively balanced capital structure, with a debt-to-equity ratio of 0.42, indicating a moderate reliance on debt financing. The company's liquidity position is assessed as medium, with a current ratio of 1.93, suggesting it can cover short-term obligations but with limited excess capacity. Free cash flow is negative at -172.08 million INR, driven by capital expenditures of -275.71 million INR, which may signal ongoing investment in operations or asset maintenance. Profitability metrics show a return on equity (ROE) of 5.86% and a return on assets (ROA) of 2.99%, both below the typical thresholds for high-performing chemical firms. Gross profit of 936.23 million INR and operating income of 158.26 million INR indicate a narrow margin structure, which is common in the commodity chemicals industry due to price sensitivity and high input costs. The company's revenue is not segmented by product or geography in the available data, but the negative free cash flow and high capital expenditures suggest a focus on maintaining or expanding production capacity. There is no indication of geographic diversification, and the company appears to be concentrated in a single ma
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
IDIO.NS maintains a relatively balanced capital structure, with a debt-to-equity ratio of 0.42, indicating a moderate reliance on debt financing. The company's liquidity position is assessed as medium, with a current ratio of 1.93, suggesting it can cover short-term obligations but with limited excess capacity. Free cash flow is negative at -172.08 million INR, driven by capital expenditures of -275.71 million INR, which may signal ongoing investment in operations or asset maintenance.
Profitability metrics show a return on equity (ROE) of 5.86% and a return on assets (ROA) of 2.99%, both below the typical thresholds for high-performing chemical firms. Gross profit of 936.23 million INR and operating income of 158.26 million INR indicate a narrow margin structure, which is common in the commodity chemicals industry due to price sensitivity and high input costs.
The company's revenue is not segmented by product or geography in the available data, but the negative free cash flow and high capital expenditures suggest a focus on maintaining or expanding production capacity. There is no indication of geographic diversification, and the company appears to be concentrated in a single market or region.
Looking ahead, the company is expected to maintain a stable revenue trajectory, with no significant growth or contraction projected in the next fiscal year. The capital expenditure outlook is neutral, with continued investment in operations expected to support production capacity. However, the negative free cash flow and high capital outlays may limit the company's ability to return value to shareholders in the near term.
Risk factors include liquidity constraints, as the company has negative net cash after subtracting total debt. The dilution risk is assessed as low, with no significant dilution expected in the near term. However, the company's reliance on debt financing and the potential for further capital expenditures could increase financial leverage and expose the company to interest rate risk.
Recent filings and transcripts do not indicate any major strategic shifts or operational disruptions. The company appears to be maintaining a steady course, with no significant events reported in the latest financial disclosures. The absence of major announcements suggests a stable but conservative operational approach.
- IDIO.NS operates in the Commodity Chemicals industry with a focus on chemical production and sales.
- The company has a moderate debt-to-equity ratio of 0.42 and a current ratio of 1.93, indicating a balanced but not robust liquidity position.
- Profitability is modest, with ROE at 5.86% and ROA at 2.99%, reflecting the competitive nature of the commodity chemicals market.
- Free cash flow is negative, driven by capital expenditures, which may limit shareholder returns in the near term.
- The company is expected to maintain a stable revenue trajectory with no significant growth or contraction projected.
- Risk factors include liquidity constraints and potential interest rate exposure due to debt financing.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- IDIO.NS Market data — financials · 2026-05-28